Biocept Inc: Rises on COVID-19 testing update
** Shares of test maker BIOC.O rise 3.2% to $5.09
premarket - highest in over two months
** BIOC says it has received more than 100,000 COVID-19
samples to date for processing urn:newsml:reuters.com:*:nPn7sLhBa
** Co expects COVID-19 testing to have positive impact on
rev through the year and into 2021
** Up to Wednesday's close, stock up 72.4% YTD
(Reporting by Amruta Khandekar)
((Amruta.Khandekar@thomsonreuters.com;))
Recent news on Biocept
See all newsBrief: Biocept Says Trading Of Common Stock Will Be Suspended By Nasdaq At Opening Of Business On Oct 25
U.S. STOCKS ON THE MOVE-Overstock.com, Biocept, Birkenstock
Biocept slumps after filing for bankruptcy protection
Brief: Biocept CEO Antonino Morales Resigns
U.S. STOCKS ON THE MOVE-Albemarle, Novavax, WeWork